Wang Xicheng相关文献与解析，生知库 | 链接生命科学的每一步

Cao, Yaxin; Wang, Xicheng; Zheng, Weilin; Chun, Fengjun; Xing, Zhifeng; Guo, Yang; Wei, Xiaohe; Chen, Jiangkun; Li, Shuohan; Fang, Yongzheng; Wang, Feng

发表日期：2026

文献求助收藏

Conversion of Transplanted Mature Hepatocytes into Afp(+) Reprogrammed Cells for Liver Regeneration After Injury.

将移植的成熟肝细胞转化为 AFP(+) 重编程细胞，用于肝脏损伤后的再生。

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202517126

Fang Ting, Yang Chao, Qiu Hua, Du Yuan, Wang Xicheng, Li Yuting, Xu Mingyang, Liu Changcheng, Li Xiuhua, Guo Na, Shi Jun, Zhang Wencheng, He Zhiying

细胞生物学

发表日期：2026

文献求助收藏

The clinical landscape of POLE-mutant colorectal cancer: a retrospective analysis of real-world outcome

POLE突变型结直肠癌的临床概况：真实世界结果的回顾性分析

期刊:BMC Medicine

影响因子:8.3

doi:10.1186/s12916-025-04611-z

Xu, Ting; Zhang, Xuhui; Wang, Zhenghang; Shen, Lin; Wang, Xicheng; Li, Jian

Toothbrush-Driven Handheld Droplet Generator for Digital LAMP and Rapid CFU Assays

用于数字LAMP和快速CFU检测的牙刷驱动手持式液滴发生器

期刊:Biosensors-Basel

影响因子:5.6

doi:10.3390/bios16010030

Lai, Xiaochen; Zhu, Yong; Yang, Mingpeng; Wang, Xicheng

发表日期：2026

文献求助收藏

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial

HIV感染者从富马酸替诺福韦酯方案立即转换至比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺方案与延迟转换方案对骨密度变化的影响：一项多中心、开放标签、随机临床试验

期刊:Infectious Diseases and Therapy

影响因子:5.3

doi:10.1007/s40121-025-01262-8

Shao, Yueming; Yang, Xinping; Yu, Jianhua; Wang, Xicheng; Wang, Jiangrong; Liu, Mei; Yang, Zongxing; Han, Jie; Zhang, Renfang; Liu, Li; Shen, Yinzhong; Sun, Meiyan; Wu, Luling; Zheng, Zhihang; Tang, Yang; Yang, Junyang; Wang, Zhenyan; Qi, Tangkai; Xu, Shuibao; Xun, Jingna; Sun, Jianjun; Song, Wei; Chen, Jun

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II study

KN026（一种双特异性抗HER2抗体）联合KN046（一种抗CTLA4/PD-L1抗体）治疗晚期HER2阳性非乳腺癌患者的疗效和安全性：一项Ib期和II期研究的联合分析

期刊:Signal Transduction and Targeted Therapy

影响因子:52.7

doi:10.1038/s41392-025-02195-x

Liu, Dan; Gong, Jifang; Li, Jian; Qi, Changsong; Niu, Zuoxing; Liu, Bo; Peng, Zhi; Luo, Suxia; Wang, Xicheng; Wang, Yakun; Zhao, Rusen; Chen, Lilin; Deng, Ting; Li, Zhen; Chen, Lei; Fang, Meimei; Yang, Hongwei; Lu, Linzhi; Zhang, Yanming; Kang, Fengling; Xu, Ting; Zhang, Xiaotian; Shen, Lin

PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial

PD-1抗体卡瑞利珠单抗联合阿帕替尼和SOX方案作为一线治疗AFP阳性胃癌或胃食管交界处腺癌患者的疗效（CAP 06）：一项多中心、单臂II期临床试验

期刊:Signal Transduction and Targeted Therapy

影响因子:52.7

doi:10.1038/s41392-025-02193-z

Wang, Yakun; Lu, Jialin; Chong, Xiaoyi; Wang, Chang; Chen, Xiaofeng; Peng, Zhi; Gu, Yanhong; Wang, Yizhuo; Wang, Xicheng; Li, Jian; Gong, Jifang; Qi, Changsong; Yuan, Jiajia; Lu, Zhihao; Lu, Ming; Zhou, Jun; Cao, Yanshuo; Chen, Yang; Zhang, Cheng; Hou, Zhiguo; Kou, Hongyi; Shen, Lin; Zhang, Xiaotian

Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST

Taletrectinib 在 ROS1+ 非小细胞肺癌中的应用：TRUST

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO-25-00275

Pérol, Maurice; Li, Wei; Pennell, Nathan A; Liu, Geoffrey; Ohe, Yuichiro; De Braud, Filippo; Nagasaka, Misako; Felip, Enriqueta; Xiong, Anwen; Zhang, Yongchang; Fan, Huijie; Wang, Xicheng; Li, Shuanglian; Lai, Rose K; Ran, Feiwu; Zhang, Xianyu; Chen, Wenfeng; Bazhenova, Lyudmila; Zhou, Caicun

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update

中国临床肿瘤学会（CSCO）：结直肠癌诊疗临床指南（2024年更新版）

期刊:Cancer Communications

影响因子:24.9

doi:10.1002/cac2.12639

Wang, Feng; Chen, Gong; Zhang, Zhen; Yuan, Ying; Wang, Yi; Gao, Yuan-Hong; Sheng, Weiqi; Wang, Zixian; Li, Xinxiang; Yuan, Xianglin; Cai, Sanjun; Ren, Li; Liu, Yunpeng; Xu, Jianmin; Zhang, Yanqiao; Liang, Houjie; Wang, Xicheng; Zhou, Aiping; Ying, Jianming; Li, Guichao; Cai, Muyan; Ji, Gang; Li, Taiyuan; Wang, Jingyu; Hu, Hanguang; Nan, Kejun; Wang, Liuhong; Zhang, Suzhan; Li, Jin; Xu, Rui-Hua

Toripalimab, bevacizumab, and irinotecan in dMMR/MSI locally advanced colorectal cancer: First-stage results from a phase 1b/2 trial

托瑞普利单抗、贝伐珠单抗和伊立替康治疗dMMR/MSI局部晚期结直肠癌：一项1b/2期试验的第一阶段结果

期刊:Cell Reports Medicine

影响因子:10.6

doi:10.1016/j.xcrm.2025.102296

Wang, Zhenghang; Wang, Xicheng; Zhang, Xiaoyan; Leng, Jiahua; Cui, Ming; Zhang, Ji; Wang, Quan; Sun, Yu; Xu, Ting; Chen, Mifen; Li, Jian; Shen, Lin

Discovering Structure-Adaptive Oxides for Embedded Epitaxial Growth of Perovskite Nanocrystals

发现用于钙钛矿纳米晶体嵌入式外延生长的结构自适应氧化物

Conversion of Transplanted Mature Hepatocytes into Afp(+) Reprogrammed Cells for Liver Regeneration After Injury.

将移植的成熟肝细胞转化为 AFP(+) 重编程细胞，用于肝脏损伤后的再生。

The clinical landscape of POLE-mutant colorectal cancer: a retrospective analysis of real-world outcome

POLE突变型结直肠癌的临床概况：真实世界结果的回顾性分析

Toothbrush-Driven Handheld Droplet Generator for Digital LAMP and Rapid CFU Assays

用于数字LAMP和快速CFU检测的牙刷驱动手持式液滴发生器

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial

HIV感染者从富马酸替诺福韦酯方案立即转换至比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺方案与延迟转换方案对骨密度变化的影响：一项多中心、开放标签、随机临床试验

Efficacy and safety of KN026, a bispecific anti-HER2 antibody, in combination with KN046, an anti-CTLA4/PD-L1 antibody, in patients with advanced HER2-positive nonbreast cancer: a combined analysis of a phase Ib and a phase II study

KN026（一种双特异性抗HER2抗体）联合KN046（一种抗CTLA4/PD-L1抗体）治疗晚期HER2阳性非乳腺癌患者的疗效和安全性：一项Ib期和II期研究的联合分析

PD-1 antibody camrelizumab plus apatinib and SOX as first-line treatment in patients with AFP-producing gastric or gastro-esophageal junction adenocarcinoma (CAP 06): a multi-center, single-arm, phase 2 trial

PD-1抗体卡瑞利珠单抗联合阿帕替尼和SOX方案作为一线治疗AFP阳性胃癌或胃食管交界处腺癌患者的疗效（CAP 06）：一项多中心、单臂II期临床试验

Taletrectinib in ROS1+ Non-Small Cell Lung Cancer: TRUST

Taletrectinib 在 ROS1+ 非小细胞肺癌中的应用：TRUST

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update

中国临床肿瘤学会（CSCO）：结直肠癌诊疗临床指南（2024年更新版）

Toripalimab, bevacizumab, and irinotecan in dMMR/MSI locally advanced colorectal cancer: First-stage results from a phase 1b/2 trial

托瑞普利单抗、贝伐珠单抗和伊立替康治疗dMMR/MSI局部晚期结直肠癌：一项1b/2期试验的第一阶段结果